BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7504828)

  • 1. Peptide binding sites recognized by anti-mucin (MUC2) monoclonal antibodies.
    Xing PX; Apostolopoulos V; Prenzoska J; Devine PL; McKenzie IF
    Scand J Immunol; 1993 Dec; 38(6):591-2. PubMed ID: 7504828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies reacting with the MUC2 mucin core protein.
    Devine PL; McGuckin MA; Birrell GW; Whitehead RH; Sachdev GP; Shield P; Ward BG
    Br J Cancer; 1993 Jun; 67(6):1182-8. PubMed ID: 8512804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune recognition of human colonic-tumour-associated MUC-2 mucins using an anti-peptide antibody.
    Price MR; Sekowski M; Ladányi A; Uray K; Ma Y; Durrant L; Tendler SJ
    Int J Cancer; 1993 Nov; 55(5):753-9. PubMed ID: 7503958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of solution conformation on antibody recognition of a protein core epitope from gastrointestinal mucin (MUC2).
    Uray K; Kajtár J; Vass E; Price MR; Hollósi M; Hudecz F
    Arch Biochem Biophys; 1999 Jan; 361(1):65-74. PubMed ID: 9882429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucin.
    Durrant LG; Jacobs E; Price MR
    Eur J Cancer; 1994; 30A(3):355-63. PubMed ID: 8204359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of distinct MUC2 mucin glycoforms using two anti-peptide monoclonal antibodies.
    Price MR; Ladányi A; Uray K; Ma Y; Sekowski M; Durrant LG
    Int J Oncol; 1999 Oct; 15(4):803-9. PubMed ID: 10493965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
    Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
    Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localisation of a protein core-specific epitope from gastrointestinal mucin (MUC2). The effect of epitope immobilisation on antibody recognition.
    Uray K; Price MR; Hudecz F
    J Pept Sci; 1998 Aug; 4(5):319-26. PubMed ID: 9753391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
    Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
    Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of D-amino acid substitution in a mucin 2 epitope on mucin-specific monoclonal antibody recognition.
    Uray K; Kajtár J; Vass E; Price MR; Hollósi M; Hudecz F
    Arch Biochem Biophys; 2000 Jun; 378(1):25-32. PubMed ID: 10871040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of anti-human milk fat globule antibodies with synthetic peptides.
    Xing PX; Tjandra JJ; Reynolds K; McLaughlin PJ; Purcell DF; McKenzie IF
    J Immunol; 1989 May; 142(10):3503-9. PubMed ID: 2715633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer.
    Xing PX; Prenzoska J; Layton GT; Devine PL; McKenzie IF
    J Natl Cancer Inst; 1992 May; 84(9):699-703. PubMed ID: 1569603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide epitopes in breast cancer mucins.
    Xing PX; Apostolopoulos V; Trapani J; Prenzoska J; McKenzie IF
    Adv Exp Med Biol; 1994; 353():9-16. PubMed ID: 7527180
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of an anti-idiotypic antibody reactive with an antibody defining the epitope RPAP in the MUC-1 epithelial mucin core.
    Bashford JL; Robins RA; Price MR
    Int J Cancer; 1993 Jul; 54(5):778-83. PubMed ID: 7686886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and solution conformation of multiple epitopes recognized by a MUC2 mucin-specific monoclonal antibody.
    Uray K; Price MR; Majer Z; Vass E; Hollósi M; Hudecz F
    Arch Biochem Biophys; 2003 Feb; 410(2):254-60. PubMed ID: 12573285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-peptide monoclonal antibodies to intestinal mucin 3.
    Apostolopoulos V; Xing PX; McKenzie IF
    J Gastroenterol Hepatol; 1995; 10(5):555-61. PubMed ID: 8963031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary structure of the variable regions of a monoclonal antibody MUSE11 recognizing the tandem repeat domain of a mucin core protein, MUC1.
    Hinoda Y; Arimura Y; Itoh F; Adachi M; Tsujisaki M; Imai K; Yachi A
    J Clin Lab Anal; 1993; 7(2):100-4. PubMed ID: 7685048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine specificity of antibody recognition of carcinoma-associated epithelial mucins: antibody binding to synthetic peptide epitopes.
    Briggs S; Price MR; Tendler SJ
    Eur J Cancer; 1993; 29A(2):230-7. PubMed ID: 7678496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heteroclitic recognition of combinatorial TX1TX2T peptide mixtures by mucin-2 protein specific monoclonal antibody.
    Windberg E; Uray K; Illyés E; Skribanek Z; Price MR; Sebestyén F; Hudecz F
    J Pept Sci; 2004 Jan; 10(1):56-65. PubMed ID: 14959892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of an antibody directed to an alpha-N-acetyl-D-galactosamine glycosylated MUC2 peptide.
    Reis CA; Sørensen T; Mandel U; David L; Mirgorodskaya E; Roepstorff P; Kihlberg J; Hansen JE; Clausen H
    Glycoconj J; 1998 Jan; 15(1):51-62. PubMed ID: 9530956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.